Secondary Logo

Journal Logo

Articles by JoAnn E. Manson, M.D., Dr.P.H.

Women's Health Initiative clinical trials potential interactive effect of calcium and vitamin D supplementation with hormonal therapy on cardiovascular disease

Jiang, Xuezhi; Nudy, Matthew; Aragaki, Aaron K.; More

Menopause. ., Post Author Corrections: May 15, 2019

The Kronos Early Estrogen Prevention Study (KEEPS) what have we learned?

Miller, Virginia M.; Naftolin, Fredrick; Asthana, Sanjay; More

Menopause. ., Post Author Corrections: April 01, 2019

Perceived social support and the risk of cardiovascular disease and all-cause mortality in the Women's Health Initiative Observational Study

Freeborne, Nancy; Simmens, Samuel J.; Manson, JoAnn E.; More

Menopause. 26(7):698-707, July 2019.

Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study

Shufelt, Chrisandra; Bairey Merz, C. Noel; Pettinger, Mary B.; More

Menopause. 25(9):985-991, September 2018.

Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials

Swica, Yael; Warren, Michelle P.; Manson, JoAnn E.; More

Menopause. 25(7):753-761, July 2018.

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS)

Cintron, Dahima; Lahr, Brian D.; Bailey, Kent R.; More

Menopause. 25(2):145-153, February 2018.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher A.; More

Menopause. 25(1):11-20, January 2018.

Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher; More

Menopause. 24(10):1145-1153, October 2017.

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study

Santoro, Nanette; Allshouse, Amanda; Neal-Perry, Genevieve; More

Menopause. 24(3):238-246, March 2017.

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial

Caan, Bette; LaCroix, Andrea Z.; Joffe, Hadine; More

Menopause. 22(6):607-615, June 2015.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Manson, JoAnn E.; Ames, Jeffrey M.; Shapiro, Marla; More

Menopause. 22(3):247-253, March 2015.

Why the product labeling for low-dose vaginal estrogen should be changed

Manson, JoAnn E.; Goldstein, Steven R.; Kagan, Risa; More

Menopause. 21(9):911-916, September 2014.

Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial

Schnatz, Peter F.; Jiang, Xuezhi; Vila-Wright, Sharon; More

Menopause. 21(8):823-833, August 2014.

Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial

Cohen, Lee S.; Joffe, Hadine; Guthrie, Katherine A.; More

Menopause. 21(4):347-354, April 2014.

Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women’s Health Initiative Observational Study

Shufelt, Chrisandra L.; Merz, C. Noel Bairey; Prentice, Ross L.; More

Menopause. 21(3):260-266, March 2014.

Coronary heart disease events in the Women’s Health Initiative hormone trials: effect modification by metabolic syndromeA nested case-control study within the Women’s Health Initiative randomized clinical trials

Wild, Robert A.; Wu, Chunyuan; Curb, J. D.; More

Menopause: The Journal of The North American Menopause Society. 20(3):254-260, March 2013.

Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative

Gass, Margery L.S.; Cochrane, Barbara B.; Larson, Joseph C.; More

Menopause. 18(11):1160-1171, November 2011.

Vasomotor symptoms and cardiovascular events in postmenopausal women

Szmuilowicz, Emily D.; Manson, JoAnn E.; Rossouw, Jacques E.; More

Menopause. 18(6):603-610, June 2011.

Vasomotor symptoms and coronary artery calcium in postmenopausal women

Allison, Matthew A.; Manson, JoAnn E.; Aragaki, Aaron; More

Menopause. 17(6):1136-1145, November-December 2010.

Dietary vitamin D and calcium intake and mammographic density in postmenopausal women

Bertone-Johnson, Elizabeth R.; Chlebowski, Rowan T.; Manson, JoAnn E.; More

Menopause. 17(6):1152-1160, November-December 2010.

Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative

Manson, JoAnn E.; Allison, Matthew A.; Carr, J. Jeffrey; More

Menopause. 17(4):683-691, July 2010.

Hormone therapy and physical function change among older women in the Women's Health Initiative: a randomized controlled trial

Michael, Yvonne L.; Gold, Rachel; Manson, JoAnn E.; More

Menopause. 17(2):295-302, March 2010.

Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study

Allison, Matthew A.; Manson, JoAnn E.; Langer, Robert D.; More

Menopause. 15(4):639-647, July-August 2008.

Show: